Christine Klein

Country flagGermany

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Pathogenic variants in PRKN cause early‐onset Parkinson's disease (PD), while the role of alpha‐synuclein in PRKN ‐PD remains uncertain. One study performed a blood‐based alpha‐synuclein seed amplification assay (SAA) in PRKN ‐PD, not detecting seed amplification in 17 PRKN ‐PD patients. By applying a methodologically different SAA focusing on neuron‐derived extracellular vesicles, we demonstrated alpha‐synuclein seed amplification in 8 of 13 PRKN ‐PD patients, challenging the view of PRKN ‐PD as a non‐synucleinopathy. Moreover, we performed blinded replication of the neuron‐derived extracellular vesicles‐dependent SAA in idiopathic PD patients and healthy controls. In conclusion, blood‐based neuron‐derived extracellular vesicles‐dependent SAA represents a promising biomarker to elucidate the underpinnings of (monogenic) PD. ANN NEUROL 2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Background Alterations in mitochondrial dysfunction have been implicated in the pathogenesis of Parkinson's disease (PD). Mitochondrial energy production is linked to glucose metabolism, and diabetes is associated with PD. However, studies investigating glucose metabolism in vivo in genetically stratified PD patients and controls have yet to be performed. Objectives The objectives of this study were to explore glucose production, gluconeogenesis, and the contribution of gluconeogenesis to glucose production in idiopathic and PRKN PD compared with healthy controls with state‐of‐the‐art biochemical methods. Methods We applied a dried‐blood sampling/gas chromatography/mass spectrometry approach to monitor fluxes in the Cori cycle in vivo. Results The contribution of gluconeogenesis to total glucose production is increased in idiopathic PD patients (n = 33), but not in biallelic PRKN mutation carriers (n = 5) compared with healthy controls (n = 13). Conclusions We provide first‐time in vivo evidence for alterations in glucose metabolism in idiopathic PD, in keeping with the epidemiological evidence for an association between PD and diabetes. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (14)

Jens C. Schwamborn

-

LUXEMBOURG
View details

Anthony Schapira

University College London

UNITED KINGDOM
View details

David Crosiers

Professor at University of Antwerp

University of Antwerp

BELGIUM
View details

Caroline Ran

Karolinska Institutet

SWEDEN
View details

Cristina Januário

University of Coimbra

PORTUGAL
View details

Esther Sammler

-

UNITED KINGDOM
View details

Karsten Hiller

Head of Department

Technische Universität Braunschweig

GERMANY
View details

Henner Hanssen

Head of Preventive Sports Medicine/ Professor

University of Basel

SWITZERLAND
View details

Huw Morris

University College London

UNITED KINGDOM
View details

Silke Appel-Cresswell

Associate Professor, tenure

The University of British Columbia

CANADA
View details

Pilar Gómez-Garre

Instituto de Biomedicina de Sevilla

SPAIN
View details

Agnita Boon

Erasmus University Rotterdam

NETHERLANDS
View details

Simone Zittel

-

GERMANY
View details

Alexander Balck

-

GERMANY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.